Delivery Order SPE2DB20D1004-SPE2DB25FNLBL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for NURTEC ODT 75 mg tablets in quantities of eight units, valued at $6,465.10. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion deadline of August 20, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a contract ceiling value of $12,422.06. This firm fixed-price delivery order is set to be completed by July 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of NURTEC ODT 75 mg tablets (8-pack quantity) valued at $14,310.29 under a firm fixed price contract. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units. This is a firm fixed-price delivery order valued at $27,389.85, with an ultimate completion date of July 15, 2025. The award was made through competitive procedures with no set-aside designation. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of NURTEC ODT 75 mg tablets (quantity 8s) valued at $15,183.65. This firm fixed price delivery order, which is not set-aside, represents a single transaction under the company's broader pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units, with a ceiling value of $9,269.04. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 29, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $33,103.74. This firm fixed price delivery order, which is not set-aside designated, will be performed at the contractor's Conshohocken, Pennsylvania facility with an ultimate completion date of September 15, 2025. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,387.60. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of September 22, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) valued at $14,104.15. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNLBLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $7,823.30. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing indefinite delivery vehicle. The order is scheduled for completion by September 29, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a comprehensive pharmaceutical support vehicle, the IDC enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. NURTEC ODT is a migraine treatment medication, consistent with the neurological and pain management pharmaceutical products that comprise a significant portion of the company's federal medical supply portfolio serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 9/26/25 |